Photo of Monica Hinds, Ph.D.

Monica Hinds Ph.D.

  • (503) 418-9309
    • Professor of Biomedical Engineering School of Medicine
    • Program in Molecular and Cellular Biosciences School of Medicine
    • M.D./Ph.D. Program Committee School of Medicine

Dr. Monica Hinds is a Professor in the Department of Biomedical Engineering at the Oregon Health & Science University (OHSU). Prior to joining OHSU, she received degrees in Mechanical Engineering, including a B.S. from the University of Pennsylvania, an M.S. from the Georgia Institute of Technology, and a Ph.D. from the Johns Hopkins University.

Her Ph.D. dissertation work focused on the fluid mechanics involved in atherogenesis, the initiation of plaque formation in arteries. Dr. Hinds then developed elastin based biomaterials in her work at Providence St. Vincent Hospital in Portland, Oregon.

In 2003, Dr. Hinds joined the newly formed Department of Biomedical Engineering at OHSU.

Dr. Hinds’s work includes the study of biomaterials for cardiovascular applications, understanding the role of cytoskeletal structure on endothelial cell functions, and the determination of the role of hyperglycemia in causing congenital heart defects. Dr. Hinds utilizes in vitro mechanistic studies coupled with in vivo animal models to apply her engineering approaches to the causes, progression and treatment of cardiovascular diseases.

Read more

Areas of interest

  • Relationship between fluid dynamics and extracellular matrix production by cells, vascular tissue engineering, role of mechanical stimulation in tissue engineered constructs, elastin based biomaterials.


  • B.S.E., University of Pennsylvania 1991
  • M.S., Georgia Institute of Technology 1992
  • Ph.D., The Johns Hopkins University 1998


  • Glynn, JJ., Hinds, M.T. Bioactive Anti-Thrombotic Modification of Decellularized Matrix for Vascular Applications. Adv Healthc Mater. 2016 Jun;5(12):1439-46. PMID: 27072858.

  • Rigg R.A., Aslan J.E., Healy L.D., Wallisch M., Thierheimer M.L., Loren C.P., Pang J., Hinds M.T., Gruber A., McCarty O.J. Oral administration of Bruton's Tyrosine Kinase (Btk) inhibitors impairs GPVI-mediated platelet function. Am J Physiol Cell Physiol. Epub 2015 Dec 9. PMID:26659727.

  • Cutiongco M.F., Anderson D.E.J., Hinds M.T., Yim E.K. In vitro and ex vivo hemocompatibility of off-the-shelf modified poly(vinyl alcohol) vascular grafts. Acta Biomater. 2015 Oct;25:97-108. Epub 2015 Jul 27.PMID: 26225735.

  • Glynn J.J., Jones C.M., Anderson D.E.J., Pavcnik D., Hinds M.T. In vivo assessment of two endothelialization approaches on bioprosthetic valves for the treatment of chronic deep venous insufficiency. J Biomed Mater Res B Appl Biomater. 2015 Aug 28. PMID: 26316151.

Additional information

Edit profile